Syneos Health

Our team enjoyed being at WPSC 2026 in Amsterdam this week, connecting with colleagues and industry peers to discuss a topic that matters across the product lifecycle: managing risk with patients in mind.   Learn more about our Global Risk Management and REMS solutions: https://lnkd.in/eXtZfFKV   Wendy Morales Oviedo #SyneosHealth #GlobalRiskManagement #WPSC2026

Heading to Cell & Gene Meeting on the Mesa in Phoenix? Let’s connect. From early development and regulatory planning to clinical operations and commercialization, every cell and gene therapy program brings its own challenges. Our team will be there to discuss how Syneos Health can help move your program forward. Book a meeting with us: https://lnkd.in/ecfeZmF2 #MeetingOnTheMesa #CellAndGeneTherapy #SyneosHealth Jim Wise Wael Harb, MD, MBA Erynn Wardwell Michael Hughes

Congratulations to our colleague Jazmin Cassinelli on completing the HBA program! Jazmín shared how the experience gave her new perspectives to bring to her work in clinical operations, along with the chance to learn from colleagues and mentors across Syneos Health. We’re proud to celebrate her achievement and the team that supported her along the way. Interested in growing your career with us in Argentina? Explore our open roles in Buenos Aires: https://lnkd.in/eEpqWsbv #SyneosHealthLife #HBABusinessWomen #CareersInArgentina

The conversations at #DPHARM2026 made one thing clear: the future of clinical development is already taking shape. Last week in Boston, industry leaders came together to challenge long-held assumptions, explore new approaches and share ideas for improving how clinical trials are designed and delivered. Our latest conference capsule captures key takeaways from across the event, from evolving operating models and AI to clinical oversight and the factors that truly influence trial performance. We also spotlight new research from Syneos Health and Tufts CSDD that brings fresh evidence to one of the industry’s most important conversations. #SyneosHealth #ClinicalDevelopment #ClinicalResearch #ClinicalTrials

For more than two decades, India has strengthened how Syneos Health serves customers around the world. Today, we're building on that foundation with the opening of our new Hyderabad office. Bringing together leadership, specialized clinical and commercial expertise, and AI and engineering talent, the new office strengthens our global capabilities and reflects our continued investment in the talent, expertise and innovation driving the future of healthcare. We were honored to welcome Sridhar Babu Duddilla, Hon'ble Minister for Information Technology, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Government of Telangana, as well as Sai Krishna 🇮🇳 and Sarvesh Singh to mark this important milestone. Located in one of India's leading life sciences and technology hubs, the 137,000-square-foot office includes advanced collaboration spaces and a dedicated training center designed to accelerate learning and strengthen technical and functional expertise. Swipe through for highlights from the inauguration and office opening activities. Harpreet Bedi Jinu Jose Madhuri Raya Mike Montello Thomas Wollman #SyneosHealth #Hyderabad #India #LifeSciences

We're thrilled to be recognized as a PM360 Magazine Innovation Award winner for Transforming IgAN Medical Education Through Immersive Spatial Computing, developed in partnership with Otsuka Pharmaceutical Companies (U.S.). This recognition demonstrates what’s possible when scientific expertise, creativity and emerging technology come together with purpose. Congratulations to the talented teams who brought this award-winning experience to life! Learn more: https://lnkd.in/eGkzYc9x

Europe remains a critical region for oncology clinical development, but where sponsors choose to conduct trials is becoming increasingly complex. As regulatory frameworks evolve, competition for experienced sites grows and oncology studies become more specialized, traditional assumptions about country and site selection may need to evolve too. New Syneos Health research explores oncology clinical trial activity across Europe, the limitations of publicly available data and what sponsors should consider when evaluating opportunities beyond traditional trial hubs. Read the full blog: https://lnkd.in/e5nZ34DR Attending #ESMO2026? Book a meeting with our oncology experts: https://lnkd.in/ezPEPgnZ #SyneosHealth #Oncology #ClinicalTrials #ClinicalResearch

The biggest AI mistake organizations make? Starting with the technology instead of the business strategy. I'm excited to join Phil Moussally and Kim Lanier on September 30 to discuss how Syneos Health and Protiviti approached AI with strategy, governance, and business outcomes first, creating a foundation for scalable growth rather than simply deploying new technology. I will get to guide them through a conversation on lessons learned and practical insights for leaders navigating their own AI journey. Sign up here! https://bit.ly/4rrYbNB Kimberly Lanier Liz Signet Phil Moussally Syneos Health #ArtificialIntelligence #DigitalTransformation #CFO #Leadership

Early phase oncology trials are growing more complex, requiring sponsors to make critical decisions around dose selection, patient identification, evidence generation and execution earlier in development. Our latest playbook explores four strategic levers for navigating this complexity, from integrated clinical and regulatory strategy and biomarker-driven trial design to operational execution and connected data and AI. Discover how bringing these capabilities together earlier can help reduce uncertainty, strengthen trial execution and support more confident development decisions. Read the full playbook: https://lnkd.in/eC2QZvt4 #SyneosHealth #Oncology #ClinicalTrials #ClinicalDevelopment

We're counting down to Impatient Health’s Pharmageddon Europe 2026.   As a sponsor of this year's event, we're excited to contribute to the conversations shaping the future of healthcare engagement. Before the event begins, join Cliff Walton and industry peers on September 24 for our pre-event webinar:   The HCP Engaged. So Why Didn't Anything Change? Moving from next best action to the decision that changes practice.   If you've ever questioned whether engagement alone is enough to drive real change, this session is for you. With just a few days to go, make sure you've secured your place. Register here: https://lnkd.in/eYumX4ax   We'll also be hosting a workshop and joining a panel at Pharmageddon, with more details to follow soon.   We hope to see you there!   #HealthcareMarketing #CommercialStrategy #SyneosHealth Syneos Health Communications